Aymon R, Mongin D, Bergstra SA, Choquette D, et al. Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study). Ann Rheum Dis 2023 Dec 8:ard-2023-224670. doi: 10.1136/ard-2023-224670.
PMID: 38071508